Dr. Moore is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
125 Lattimore Rd
Ste 258
Rochester, NY 14620Phone+1 585-442-8020Fax+1 585-442-8039
Summary
- I am Board Certified in Gynecologic Oncology and Obstetrics and Gynecology. I am a Fellow of the ACOG and a Fellow American College of Surgeons
Education & Training
- Women and Infants Hospital of Rhode Island/Brown UniversityFellowship, Gynecologic Oncology, 1999 - 2002
- Eastern Virginia Medical SchoolResidency, Obstetrics and Gynecology, 1993 - 1997
- University of AlbertaClass of 1993
Certifications & Licensure
- NY State Medical License 2015 - 2026
- MA State Medical License 2001 - 2016
- RI State Medical License 1999 - 2016
- CT State Medical License 2002 - 2015
- NC State Medical License 1997 - 2003
- VA State Medical License 1996 - 2002
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Ovarian Cancer Risk Estimation in Patients With Pelvic Mass Start of enrollment: 2009 Oct 01
- Evaluation of Multiple Protein and Molecular Biomarkers to Estimate Risk of Cancer in Gynecology Patients Presenting With a Pelvic Mass. Start of enrollment: 2016 Jun 30
- EP0057 in Combination With Olaparib in Advanced Ovarian Cancer Start of enrollment: 2020 Dec 14
Roles: Contact
Publications & Presentations
PubMed
- 1166 citationsNiraparib in Patients with Newly Diagnosed Advanced Ovarian CancerAntonio González-Martín, Bhavana Pothuri, Ignace Vergote, René dePont Christensen, Whitney Graybill
The New England Journal of Medicine. 2019-09-28 - 90 citationsEffects of cognitive therapy on psychological symptoms and social functioning in residual depressionJan Scott, John D. Teasdale, Eugene S. Paykel, Anthony L. Johnson, Rosemary Abbott
The British Journal of Psychiatry. 2000-11-01 - 416 citationsMetacognitive awareness and prevention of relapse in depression: Empirical evidenceJohn D. Teasdale, Richard G. Moore, Hazel Hayhurst, Marie Pope, Susan Williams
Journal of Consulting and Clinical Psychology. 2002-04-01
Press Mentions
- Targeted Treatment for Ovarian Cancer DiscoveredFebruary 19th, 2014
- FDA Clears Biomarker Test for Ovarian CancerSeptember 6th, 2011
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: